within Pharmacolibrary.Drugs.ATC.M;

model M05BA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.007,
    Cl             = 2.3666666666666667,
    adminDuration  = 600,
    adminMass      = 0.07,
    adminCount     = 1,
    Vd             = 0.028,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00012333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Alendronic acid is a bisphosphonate drug used primarily to treat and prevent osteoporosis in postmenopausal women and to treat Paget's disease of bone. It works by inhibiting bone resorption by osteoclasts and is currently approved and widely used for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li>A G Porras, S D Holland, B J Gertz,Pharmacokinetics of alendronate.,Clinical pharmacokinetics,1999<a href='https://pubmed.ncbi.nlm.nih.gov/10384857/'>https://pubmed.ncbi.nlm.nih.gov/10384857/</a></li><li>Lars E Schmidt, Kim Dalhoff,Food-drug interactions.,Drugs,2002<a href='https://pubmed.ncbi.nlm.nih.gov/12093316/'>https://pubmed.ncbi.nlm.nih.gov/12093316/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end M05BA04;
